Mismatched Priorities Extend Lab Market Woes
Commercial landlords’ business model and small biotech companies’ needs are at odds, throwing obstacles in the paths of filling empty lab buildings and form the next generation of industry giants, alike.
Commercial landlords’ business model and small biotech companies’ needs are at odds, throwing obstacles in the paths of filling empty lab buildings and form the next generation of industry giants, alike.
As life science tenant space requirements become scarcer in the more conservative venture capital climate, Boston area developers are adapting to the new leasing landscape with incubator space aimed at small startups.
The latest batch of employment data estimated that Massachusetts had about 181,000 unemployed workers in January, a month when the statewide count of jobs stood 131,000 below where it was before COVID-19 hit.
Massachusetts Institute of Technology is selling a partial ownership of its 1 Portland St. and 610 and 700 Main St. office and lab buildings to Boston-based Bulfinch Cos. and Harrison Street Capital in a deal valued at $1.1 billion, or $1,626 per square foot.